← Back to Clinical Trials
Recruiting NCT07410949

NCT07410949 Postpartum Acupressure Education and Breastfeeding Outcomes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07410949
Status Recruiting
Phase
Sponsor Nigde Omer Halisdemir University
Condition Breastfeeding
Study Type INTERVENTIONAL
Enrollment 360 participants
Start Date 2026-04-25
Primary Completion 2027-02-15

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Postpartum Acupressure Education Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 360 participants in total. It began in 2026-04-25 with a primary completion date of 2027-02-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial evaluates whether acupressure education provided to mothers within the first 48 hours postpartum improves exclusive breastfeeding rates at 6 months compared with standard postpartum care alone. Mothers in the intervention group will receive structured education on self-administered acupressure at selected points and will be encouraged to continue home-based practice, while the control group will receive standard breastfeeding support. Participants will be followed for 12 months to assess breastfeeding continuation, breastfeeding self-efficacy, breastfeeding quality, and breastfeeding-related outcomes.

Eligibility Criteria

Inclusion Criteria: * Age 18 to 45 years * Term singleton birth (≥37 weeks of gestation) * ≤48 hours postpartum at the time of enrollment * Intention to breastfeed * Ability to communicate in Turkish * Access to a smartphone for educational materials and follow-up reminders * Willingness to provide written informed consent Exclusion Criteria: * Contraindications to breastfeeding (e.g., infant galactosemia) * Severe neonatal condition preventing breastfeeding * Severe maternal medical or psychiatric condition interfering with breastfeeding * Current opioid, alcohol, or substance dependence * Multiple gestation pregnancy * Severe breast injury or condition within the first 72 hours postpartum preventing breastfeeding

Contact & Investigator

Central Contact

Pınar Erdoğan, Assoc. Prof.

✉ drpinarerdogan@gmail.com

📞 +905233646954

Frequently Asked Questions

Who can join the NCT07410949 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Breastfeeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07410949 currently recruiting?

Yes, NCT07410949 is actively recruiting participants. Contact the research team at drpinarerdogan@gmail.com for enrollment information.

Where is the NCT07410949 trial being conducted?

This trial is being conducted at Niğde, Turkey (Türkiye).

Who is sponsoring the NCT07410949 clinical trial?

NCT07410949 is sponsored by Nigde Omer Halisdemir University. The trial plans to enroll 360 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology